Disease, Infectious, Effectiveness, Respiratory Disease, Safety Issues
Conditions
Brief summary
A randomized controlled clinical trial will be carried out using inspiratory and expiratory training devices on healthy subjects recruited in social networks and university environments. The aim will be to determine the effectiveness and safety in the prevention and severity of COVID-19 disease by a respiratory training with inspiratory and expiratory devices.
Interventions
Inspiratory training by a Power-breath device
Expiratory training a Winner-flow device
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy subjects
Exclusion criteria
* Drugs * Surgery * Neurology diseases * Rheumatic diseases * Systemic diseases * Smokers
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| COVID-19 disease diagnosis | Change from Baseline COVID-19 disease diagnosis at 8 weeks | Dichotomous categorical variable measured by yes or no responses |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| COVID-19 disease symptoms severity | Change from Baseline COVID-19 disease symptoms severity at 8 weeks | Dichotomous categorical variable measured by slight or severe responses |
| Adverse effects | Change from Baseline adverse effects at 8 weeks | Polytomous categorical variable measured by adverse effects responses |